BPIM
IDXX icon

Brant Point Investment Management’s Idexx Laboratories IDXX Stock Holding History

Brant Point Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.26M Buy
+58
New +$37.2K 0.42% 75
2025
Q4 		– Sell
-7,100
Closed -$4.54M – 136
2025
Q3 		$4.54M Buy
+7,100
New +$4.31M 0.49% 50

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brant Point Investment Management's IDXX Position: Q1 2026 in Review

Brant Point Investment Management reduced its Idexx Laboratories (IDXX) stake by 4.6% in Q1 2026, selling an estimated $290K and leaving 9,431 shares worth $5.3M. The position accounts for 0.68% of the portfolio, ranked #34.

Brant Point Investment Management first reported a position in IDXX in Q4 2024 and has held it in 6 quarters since. The position peaked at $6.69M in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Brant Point Investment Management held 9,431 shares of Idexx Laboratories worth $5.3M as of Q1 2026.
  • Brant Point Investment Management sold 453 Idexx Laboratories shares in Q1 2026, an estimated $290K.
  • Idexx Laboratories made up 0.68% of Brant Point Investment Management's portfolio in Q1 2026, its #34 holding.
  • Brant Point Investment Management first reported a position in Idexx Laboratories in Q4 2024 and has held it in 6 quarters since.
  • Brant Point Investment Management's Idexx Laboratories position peaked at $6.69M in Q4 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Brant Point Investment Management's 13F filing for Q1 2026, filed 14 May 2026.